Date: 17 Sep 2012
A Double-Blind Comparison of Lysine Acetylsalicylate plus Metoclopramide vs Ergotamine plus Caffeine in Migraine
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Gastrointestinal symptoms in patients with migraine are not only distressing, but also hinder the absorption of oral antimigraine medication. The present study was specifically designed to compare the efficacy of lysine acetylsalicylate plus metoclopramide (LAS+MTC) and ergotamine plus caffeine (ERG+CAF) against nausea, vomiting and headache in migraine.
Patients and Study Design
Patients meeting International Headache Society criteria were randomised to double-blind treatment with LAS+MTC (1620mg LAS equivalent to 900mg aspirin + 10mg MTC) or ERG+CAF (2mg ERG plus 200mg CAF). Data were collected by means of patient diaries during a 28-day study period. The primary endpoint was the number of patients having no nausea or vomiting after the first drug intake. Headache relief (complete relief and relief from headache intensity) was part of the secondary efficacy criteria.
126 patients were randomised to LAS+MTC and 124 to ERG+CAF. Significantly more LAS+MTC-treated patients than ERG+CAF-treated patients were free of nausea or vomiting two hours after a single administration (65% vs 40%, respectively; p = 0.001). Relief from headache intensity (Glaxo criterion) according to a four-point classification was achieved in a significantly greater proportion of LAS+MTC-treated patients than of ERG+CAF-treated patients (77% vs 61%, respectively; p = 0.01). Adverse events were reported in 17% of patients on LAS+MTC compared with 23% on ERG+CAF.
With the present study doses, LAS+MTC was significantly more effective than ERG+CAF at relieving migraine attack symptoms, particularly the associated nausea and vomiting.
Rose CF. The history of migraine from Mesopotamia to medieval times. Cephalalgia 1995 Oct; 15Suppl. 15: 1–3PubMed
Hughes F-C, Lacoste J-P, Danchot J, et al. Repeated doses of combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine. Headache 1997 Jul–Aug; 37(7): 452–54CrossRef
Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 1975; 2: 57–63PubMed
Pradalier A, Guérard Des Lauriers A, Scheck F, et al. Association carbasalate calcique-metoclopramide versus dihydroergotamine dans le traitement de la crise de migraine [in French]. Path Biol 1995 Nov; 43(9): 806–13
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8Suppl. 7: 1–96
The Oral Sumatriptan Dose-Defining Study Group: Sumatriptan — an oral dose-defining study. Eur J Neurol 1991; 31: 300–5CrossRef
- A Double-Blind Comparison of Lysine Acetylsalicylate plus Metoclopramide vs Ergotamine plus Caffeine in Migraine
Clinical Drug Investigation
Volume 21, Issue 2 , pp 87-94
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Servicio de Neurologia, Institut Universitori Dexeus (Neurodex), Po de la Bonanova, 56 - Bajos, 08017, Barcelona, Spain
- 2. Servicio de Neurologia, Clinica Puerta de Hierro, Madrid, Spain
- 3. Serviço de Neurologia, Hospital de Sao Joao, Porto, Portugal
- 4. Servicio de Neurologia, Hospital Xeral, Santiago de Compostela, Spain
- 5. Serviço de Neurologia, Hospital Geral de Santo Antonio, Porto, Portugal